
The authors found concurrent growth in pharmacy benefit manager market concentration and worsening of patient access measures across states from 2016 to 2025.
Supplements and Featured Publications
This opinion paper, developed by a multidisciplinary panel of HIV experts in 2019 reflects the group’s consensus on recommendations for various stakeholders who work to improve HIV care, including population health decision-makers (such as formulary committees, pharmacy benefit managers, and clinical advisors), advocacy organizations, and local, state, and federal policy makers.